Table 3.
Type of BrdU+ cells | A05 | A10 | A11 | A12 | A14 | Weighted average∗ |
---|---|---|---|---|---|---|
BrdU+Mac387+ cells vs all BrdU+ cells† | 51.4 ± 10.8 | 91.1 ± 3.9 | 98.9 ± 1.1 | 87.3 ± 8.9 | 75.7 ± 5.7 | 78.1 ± 3.5 |
BrdU+CD68+ cells vs all BrdU+ cells‡ | 5.4 ± 3.1 | 12.2 ± 2.8 | 3.4 ± 2.0 | 5.9 ± 1.2 | 6.2 ± 2.4 | 6.9 ± 1.1 |
BrdU+Mac387+ cells vs all Mac387+ cells§ | 35.2 ± 8.7 | 75.7 ± 3.7 | 90.6 ± 2.6 | 96.0 ± 1.7 | 82.1 ± 2.9 | 74.5 ± 2.2 |
BrdU+CD68+ cells vs all CD68+ cells¶ | 2.1 ± 1.4 | 2.4 ± 0.8 | 1.9 ± 0.9 | 1.4 ± 0.3 | 2.4 ± 1.3 | 2.1 ± 0.5 |
BrdU, 5-bromo-2-deoxyuridine; DRG, dorsal root ganglion.
The averages shown are the weighted averages ± SEM (pooled variance).
Means ± SEM of the percentage of BrdU+ cells expressing Mac387 surrounding DRG neurons were calculated as follows: (number of BrdU+Mac387+ cells/total number of BrdU+ cells) × 100.
Means ± SEM of the percentage of BrdU+ cells expressing CD68 were calculated as follows: (number of BrdU+CD68+ cells/total number of BrdU+ cells) × 100.
Means ± SEM of the percentage of Mac387+ cells expressing BrdU were calculated as follows: (number of BrdU+Mac387+ cells/total number of Mac387+ cells) × 100.
Means ± SEM of the percentage of CD68+ cells expressing BrdU were calculated as follows: (number of BrdU+CD68+ cells/total number of CD68+ cells) × 100.